# Prevenar13 Post Market Surveillance

> **NCT01509105** · — · COMPLETED · sponsor: **Pfizer** · enrollment: 649 (actual)

## Conditions studied

- Healthy

## Interventions

- **BIOLOGICAL:** 13-valent pneumococcal vaccine

## Key facts

- **NCT ID:** NCT01509105
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-09
- **Primary completion:** 2016-01
- **Final completion:** 2016-01
- **Target enrollment:** 649 (ACTUAL)
- **Last updated:** 2017-02-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01509105

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01509105, "Prevenar13 Post Market Surveillance". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT01509105. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*